Disciplined Growth Investors Inc Myriad Genetics Inc Call Options Transaction History
Disciplined Growth Investors Inc
- $4.29 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
241Shares Held
95.3MCall Options Held
95.4KPut Options Held
18.2K-
Black Rock Inc. New York, NY15.2MShares$59.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$41.7 Million0.0% of portfolio
-
State Street Corp Boston, MA5.27MShares$20.6 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$18 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.07MShares$15.9 Million0.02% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $315M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...